Preferable effects of pemafibrate on liver function and fibrosis in subjects with type 2 diabetes complicated with liver damage

Abstract Background Pemafibrate has been reported to ameliorate lipid profiles and liver dysfunction. However, which patients derive benefit from the hepatoprotective effects of pemafibrate is unclear. Methods We conducted a sub-analysis of the PARM-T2D study where subjects with type 2 diabetes comp...

Полное описание

Библиографические подробности

Главные авторы:	Hiroshi Nomoto, Kenichi Kito, Hiroshi Iesaka, Takahisa Handa, Shingo Yanagiya, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, So Nagai, Ichiro Sakuma, Akinobu Nakamura, Tatsuya Atsumi
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2023-10-01
Серии:	Diabetology & Metabolic Syndrome
Предметы:	Pemafibrate Liver function Type 2 Diabetes
Online-ссылка:	https://doi.org/10.1186/s13098-023-01187-7
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!